Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: a study in healthy men

To study the effects of prednisolone (PRED) and dexamethasone (DEXA) in assumed clinically equivalent doses towards the lowering of cortisol, osteocalcin (OC) and the stimulated rise of eosinophilic cationic protein (ECP) by granulocyte colony stimulating factor (G-CSF). At four separate sessions of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical pharmacology 2003-03, Vol.58 (11), p.733-737
Hauptverfasser: DUBOIS, E. F. L, DERKS, M. G. M, ZWINDERMAN, A. H, DEKHUIJZEN, P. N. R, BOXTEL, C. J, SCHWEITZER, D. H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 737
container_issue 11
container_start_page 733
container_title European journal of clinical pharmacology
container_volume 58
creator DUBOIS, E. F. L
DERKS, M. G. M
ZWINDERMAN, A. H
DEKHUIJZEN, P. N. R
BOXTEL, C. J
SCHWEITZER, D. H
description To study the effects of prednisolone (PRED) and dexamethasone (DEXA) in assumed clinically equivalent doses towards the lowering of cortisol, osteocalcin (OC) and the stimulated rise of eosinophilic cationic protein (ECP) by granulocyte colony stimulating factor (G-CSF). At four separate sessions of 25 h each, saline i.v. alone, G-CSF s.c. alone or in combination with either 12.5 mg PRED i.v. or 2.0 mg DEXA i.v., were randomly administered in eight healthy male subjects. All subjects had equal lowering of cortisol after DEXA and PRED at 10 h, whereas a sustained suppression at 25 h persisted only after administration of DEXA. Between 4 h and 10 h after administration of DEXA and PRED, the change in the area under the concentration-time curve (DeltaAUC4-10) of OC became 24.4% and 2.3% lower, respectively ( p
doi_str_mv 10.1007/s00228-002-0549-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73098086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73098086</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-6458a2939030aaee339e2d9310ddaec173ae8dd5e2c709956400471403fe64923</originalsourceid><addsrcrecordid>eNpd0UuLFDEQAOBGFHdd_QFeJAh6a608-hFvy_qEBS96bsqkhsmSSWa70ursH_JvmnYGFrwkIfmqqFQ1zXMJbyTA8JYBlBrburbQGdvePWjOpdGqlWDkw-YcQMu2twOcNU-YbwBkZ0E_bs6k6rWxgz1v_rwPXEJyRaArIScWeSP2M_kUOMecSGDywtNv3FHZIq83Jf_C2VfJhbLD6EL6pyhzSHm_DTE44XBNVw_7OReqYkXMy468cDHUF4zxIOh2CT8xUirCZyZ-J1BwWfxh9VvCWLYHsaP0tHm0wcj07LRfNN8_fvh29bm9_vrpy9Xldet0Z0rbm25EZXX9JiASaW1JeasleI_k5KCRRu87Um4Aa7veAJhBGtAb6o1V-qJ5fcxby75diMu0C-woRkyUF54GDXaEsa_w5X_wJi9zqrVNShozjN2gK5JH5ObMPNNm2s9hh_NhkjCtI5yOI5zqOq0jnO5qzItT4uVHbdZ9xGlmFbw6AeTaxM2MyQW-d6ZXlSr9F-zcp50</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214478573</pqid></control><display><type>article</type><title>Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: a study in healthy men</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>DUBOIS, E. F. L ; DERKS, M. G. M ; ZWINDERMAN, A. H ; DEKHUIJZEN, P. N. R ; BOXTEL, C. J ; SCHWEITZER, D. H</creator><creatorcontrib>DUBOIS, E. F. L ; DERKS, M. G. M ; ZWINDERMAN, A. H ; DEKHUIJZEN, P. N. R ; BOXTEL, C. J ; SCHWEITZER, D. H</creatorcontrib><description>To study the effects of prednisolone (PRED) and dexamethasone (DEXA) in assumed clinically equivalent doses towards the lowering of cortisol, osteocalcin (OC) and the stimulated rise of eosinophilic cationic protein (ECP) by granulocyte colony stimulating factor (G-CSF). At four separate sessions of 25 h each, saline i.v. alone, G-CSF s.c. alone or in combination with either 12.5 mg PRED i.v. or 2.0 mg DEXA i.v., were randomly administered in eight healthy male subjects. All subjects had equal lowering of cortisol after DEXA and PRED at 10 h, whereas a sustained suppression at 25 h persisted only after administration of DEXA. Between 4 h and 10 h after administration of DEXA and PRED, the change in the area under the concentration-time curve (DeltaAUC4-10) of OC became 24.4% and 2.3% lower, respectively ( p&lt;0.0001). After 25 h, this effect persisted for DEXA. DeltaAUC4-10 of the G-CSF-stimulated ECP response decreased by a mean of 76.8% after PRED compared with DEXA and to controls ( p&lt;0.02), and this difference had disappeared at 25 h. DEXA did not elicit any effect towards the G-CSF-stimulated ECP response. PRED and DEXA in formerly assumed clinically equivalent doses induced a similar suppression towards cortisol within the first 10 h, but had different actions towards blood concentrations of OC and ECP following G-CSF stimulation in healthy male subjects.</description><identifier>ISSN: 0031-6970</identifier><identifier>EISSN: 1432-1041</identifier><identifier>DOI: 10.1007/s00228-002-0549-z</identifier><identifier>PMID: 12634979</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adult ; Anti-Inflammatory Agents - administration &amp; dosage ; Anti-Inflammatory Agents - pharmacology ; Biological and medical sciences ; Biomarkers - analysis ; Blood Proteins - metabolism ; Dexamethasone - administration &amp; dosage ; Dexamethasone - pharmacology ; Dose-Response Relationship, Drug ; Eosinophil Granule Proteins ; Granulocyte Colony-Stimulating Factor - pharmacology ; Hormones. Endocrine system ; Humans ; Hydrocortisone - blood ; Male ; Medical sciences ; Middle Aged ; Osteocalcin - blood ; Pharmacology. Drug treatments ; Prednisolone - administration &amp; dosage ; Prednisolone - pharmacology ; Ribonucleases ; Time Factors</subject><ispartof>European journal of clinical pharmacology, 2003-03, Vol.58 (11), p.733-737</ispartof><rights>2003 INIST-CNRS</rights><rights>Springer-Verlag 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-6458a2939030aaee339e2d9310ddaec173ae8dd5e2c709956400471403fe64923</citedby><cites>FETCH-LOGICAL-c354t-6458a2939030aaee339e2d9310ddaec173ae8dd5e2c709956400471403fe64923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14622632$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12634979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DUBOIS, E. F. L</creatorcontrib><creatorcontrib>DERKS, M. G. M</creatorcontrib><creatorcontrib>ZWINDERMAN, A. H</creatorcontrib><creatorcontrib>DEKHUIJZEN, P. N. R</creatorcontrib><creatorcontrib>BOXTEL, C. J</creatorcontrib><creatorcontrib>SCHWEITZER, D. H</creatorcontrib><title>Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: a study in healthy men</title><title>European journal of clinical pharmacology</title><addtitle>Eur J Clin Pharmacol</addtitle><description>To study the effects of prednisolone (PRED) and dexamethasone (DEXA) in assumed clinically equivalent doses towards the lowering of cortisol, osteocalcin (OC) and the stimulated rise of eosinophilic cationic protein (ECP) by granulocyte colony stimulating factor (G-CSF). At four separate sessions of 25 h each, saline i.v. alone, G-CSF s.c. alone or in combination with either 12.5 mg PRED i.v. or 2.0 mg DEXA i.v., were randomly administered in eight healthy male subjects. All subjects had equal lowering of cortisol after DEXA and PRED at 10 h, whereas a sustained suppression at 25 h persisted only after administration of DEXA. Between 4 h and 10 h after administration of DEXA and PRED, the change in the area under the concentration-time curve (DeltaAUC4-10) of OC became 24.4% and 2.3% lower, respectively ( p&lt;0.0001). After 25 h, this effect persisted for DEXA. DeltaAUC4-10 of the G-CSF-stimulated ECP response decreased by a mean of 76.8% after PRED compared with DEXA and to controls ( p&lt;0.02), and this difference had disappeared at 25 h. DEXA did not elicit any effect towards the G-CSF-stimulated ECP response. PRED and DEXA in formerly assumed clinically equivalent doses induced a similar suppression towards cortisol within the first 10 h, but had different actions towards blood concentrations of OC and ECP following G-CSF stimulation in healthy male subjects.</description><subject>Adult</subject><subject>Anti-Inflammatory Agents - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - analysis</subject><subject>Blood Proteins - metabolism</subject><subject>Dexamethasone - administration &amp; dosage</subject><subject>Dexamethasone - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Eosinophil Granule Proteins</subject><subject>Granulocyte Colony-Stimulating Factor - pharmacology</subject><subject>Hormones. Endocrine system</subject><subject>Humans</subject><subject>Hydrocortisone - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Osteocalcin - blood</subject><subject>Pharmacology. Drug treatments</subject><subject>Prednisolone - administration &amp; dosage</subject><subject>Prednisolone - pharmacology</subject><subject>Ribonucleases</subject><subject>Time Factors</subject><issn>0031-6970</issn><issn>1432-1041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0UuLFDEQAOBGFHdd_QFeJAh6a608-hFvy_qEBS96bsqkhsmSSWa70ursH_JvmnYGFrwkIfmqqFQ1zXMJbyTA8JYBlBrburbQGdvePWjOpdGqlWDkw-YcQMu2twOcNU-YbwBkZ0E_bs6k6rWxgz1v_rwPXEJyRaArIScWeSP2M_kUOMecSGDywtNv3FHZIq83Jf_C2VfJhbLD6EL6pyhzSHm_DTE44XBNVw_7OReqYkXMy468cDHUF4zxIOh2CT8xUirCZyZ-J1BwWfxh9VvCWLYHsaP0tHm0wcj07LRfNN8_fvh29bm9_vrpy9Xldet0Z0rbm25EZXX9JiASaW1JeasleI_k5KCRRu87Um4Aa7veAJhBGtAb6o1V-qJ5fcxby75diMu0C-woRkyUF54GDXaEsa_w5X_wJi9zqrVNShozjN2gK5JH5ObMPNNm2s9hh_NhkjCtI5yOI5zqOq0jnO5qzItT4uVHbdZ9xGlmFbw6AeTaxM2MyQW-d6ZXlSr9F-zcp50</recordid><startdate>20030301</startdate><enddate>20030301</enddate><creator>DUBOIS, E. F. L</creator><creator>DERKS, M. G. M</creator><creator>ZWINDERMAN, A. H</creator><creator>DEKHUIJZEN, P. N. R</creator><creator>BOXTEL, C. J</creator><creator>SCHWEITZER, D. H</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20030301</creationdate><title>Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: a study in healthy men</title><author>DUBOIS, E. F. L ; DERKS, M. G. M ; ZWINDERMAN, A. H ; DEKHUIJZEN, P. N. R ; BOXTEL, C. J ; SCHWEITZER, D. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-6458a2939030aaee339e2d9310ddaec173ae8dd5e2c709956400471403fe64923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Anti-Inflammatory Agents - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - analysis</topic><topic>Blood Proteins - metabolism</topic><topic>Dexamethasone - administration &amp; dosage</topic><topic>Dexamethasone - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Eosinophil Granule Proteins</topic><topic>Granulocyte Colony-Stimulating Factor - pharmacology</topic><topic>Hormones. Endocrine system</topic><topic>Humans</topic><topic>Hydrocortisone - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Osteocalcin - blood</topic><topic>Pharmacology. Drug treatments</topic><topic>Prednisolone - administration &amp; dosage</topic><topic>Prednisolone - pharmacology</topic><topic>Ribonucleases</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DUBOIS, E. F. L</creatorcontrib><creatorcontrib>DERKS, M. G. M</creatorcontrib><creatorcontrib>ZWINDERMAN, A. H</creatorcontrib><creatorcontrib>DEKHUIJZEN, P. N. R</creatorcontrib><creatorcontrib>BOXTEL, C. J</creatorcontrib><creatorcontrib>SCHWEITZER, D. H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DUBOIS, E. F. L</au><au>DERKS, M. G. M</au><au>ZWINDERMAN, A. H</au><au>DEKHUIJZEN, P. N. R</au><au>BOXTEL, C. J</au><au>SCHWEITZER, D. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: a study in healthy men</atitle><jtitle>European journal of clinical pharmacology</jtitle><addtitle>Eur J Clin Pharmacol</addtitle><date>2003-03-01</date><risdate>2003</risdate><volume>58</volume><issue>11</issue><spage>733</spage><epage>737</epage><pages>733-737</pages><issn>0031-6970</issn><eissn>1432-1041</eissn><abstract>To study the effects of prednisolone (PRED) and dexamethasone (DEXA) in assumed clinically equivalent doses towards the lowering of cortisol, osteocalcin (OC) and the stimulated rise of eosinophilic cationic protein (ECP) by granulocyte colony stimulating factor (G-CSF). At four separate sessions of 25 h each, saline i.v. alone, G-CSF s.c. alone or in combination with either 12.5 mg PRED i.v. or 2.0 mg DEXA i.v., were randomly administered in eight healthy male subjects. All subjects had equal lowering of cortisol after DEXA and PRED at 10 h, whereas a sustained suppression at 25 h persisted only after administration of DEXA. Between 4 h and 10 h after administration of DEXA and PRED, the change in the area under the concentration-time curve (DeltaAUC4-10) of OC became 24.4% and 2.3% lower, respectively ( p&lt;0.0001). After 25 h, this effect persisted for DEXA. DeltaAUC4-10 of the G-CSF-stimulated ECP response decreased by a mean of 76.8% after PRED compared with DEXA and to controls ( p&lt;0.02), and this difference had disappeared at 25 h. DEXA did not elicit any effect towards the G-CSF-stimulated ECP response. PRED and DEXA in formerly assumed clinically equivalent doses induced a similar suppression towards cortisol within the first 10 h, but had different actions towards blood concentrations of OC and ECP following G-CSF stimulation in healthy male subjects.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>12634979</pmid><doi>10.1007/s00228-002-0549-z</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-6970
ispartof European journal of clinical pharmacology, 2003-03, Vol.58 (11), p.733-737
issn 0031-6970
1432-1041
language eng
recordid cdi_proquest_miscellaneous_73098086
source MEDLINE; SpringerLink Journals
subjects Adult
Anti-Inflammatory Agents - administration & dosage
Anti-Inflammatory Agents - pharmacology
Biological and medical sciences
Biomarkers - analysis
Blood Proteins - metabolism
Dexamethasone - administration & dosage
Dexamethasone - pharmacology
Dose-Response Relationship, Drug
Eosinophil Granule Proteins
Granulocyte Colony-Stimulating Factor - pharmacology
Hormones. Endocrine system
Humans
Hydrocortisone - blood
Male
Medical sciences
Middle Aged
Osteocalcin - blood
Pharmacology. Drug treatments
Prednisolone - administration & dosage
Prednisolone - pharmacology
Ribonucleases
Time Factors
title Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: a study in healthy men
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A18%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Distinct%20actions%20of%20prednisolone%20and%20dexamethasone%20towards%20osteocalcin%20and%20eosinophilic%20cationic%20protein%20in%20assumed%20clinically%20equivalent%20doses:%20a%20study%20in%20healthy%20men&rft.jtitle=European%20journal%20of%20clinical%20pharmacology&rft.au=DUBOIS,%20E.%20F.%20L&rft.date=2003-03-01&rft.volume=58&rft.issue=11&rft.spage=733&rft.epage=737&rft.pages=733-737&rft.issn=0031-6970&rft.eissn=1432-1041&rft_id=info:doi/10.1007/s00228-002-0549-z&rft_dat=%3Cproquest_cross%3E73098086%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=214478573&rft_id=info:pmid/12634979&rfr_iscdi=true